Berardinelli-Seip congenital lipodystrophy 2 (BSCL2) is caused by loss-of-function mutations in SEIPIN, a protein implicated in both adipogenesis and lipid droplet expansion but whose molecular function remains obscure. Here, we identify physical and functional interactions between SEIPIN and microsomal isoforms of glycerol-3-phosphate acyltransferase (GPAT) in
INTRODUCTION
Congenital generalized lipodystrophy (CGL; also known as Berardinelli-Seip congenital lipodystrophy [BSCL] ) is an autosomal recessive disorder characterized by a near total loss of adipose tissue, severe hypertriglyceridemia, insulin resistance, and fatty liver (Agarwal and Garg, 2006; Magré et al., 2001 ). To date, four genes have been linked to CGL/BSCL: 1-acylglycerol-3-phosphate-O-acyltransferase-2 (AGPAT2)/CGL1, SEIPIN/CGL2, CAVEOLIN-1/CGL3, and CAVIN-1/CGL4 (Fei et al., 2011a) . The most severe form of human CGL/BSCL is caused by loss-of-function mutations in SEIPIN/BSCL2, which encodes an integral membrane protein of the endoplasmic reticulum (ER) with no recognizable functional domains (Fei et al., 2011a; Cartwright and Goodman, 2012; Lundin et al., 2006) . Seipin knockout (Bscl2 −/− ) mice have severe lipodystrophy and insulin resistance (Cui et al., 2011; Chen et al., 2012; Prieur et al., 2013) , demonstrating an essential role for Seipin in adipogenesis. SEIPIN and its non-mammalian orthologs also control the expansion of lipid droplets (LDs). The most prominent feature of Seipin-deficient cells is the formation of "supersized" LDs (Fei et al., 2008 (Fei et al., , 2011b Szymanski et al., 2007; Tian et al., 2011; Jiang et al., 2014; Liu et al., 2014) . Thus, SEIPIN has a unique role in regulating both systemic (adipogenesis) and cellular (LD expansion) lipid storage.
Recent studies implicate SEIPIN and its yeast ortholog, Fld1 (also known as Sei1), in regulating phospholipid metabolism such that the amount of phosphatidic acid (PA) is increased in SEIPIN-deficient cells and tissues (Fei et al., 2011c; Sim et al., 2012; Wolinski et al., 2015; Han et al., 2015) . We have postulated that in preadipocytes, increased PA acts as a peroxisome proliferator-activated receptor gamma (PPARγ) antagonist and thus blocks adipogenesis (Stapleton et al., 2011; Fei et al., 2011a) . In nonpreadipocytes and yeast, PA promotes LD expansion, likely because it is fusogenic (Fei et al., 2011c) . However, exactly how the ER-localized SEIPIN might regulate the metabolism of phospholipids and PA remains unknown.
Through affinity isolation and tandem mass spectrometry analyses, we identified proteins that specifically co-precipitate with Fld1-GFP in the yeast Saccharomyces cerevisiae. The most prominent of these proteins was Gat1, a glycerol-3-phosphate acyltransferase (GPAT). As the rate-limiting step in the synthesis of triacylglycerol and glycerophospholipids, GPAT catalyzes the esterification of glycerol-3-phosphate with a long-chain acyl-coenzyme A (acetyl-CoA) to initiate the formation of PA (Cao et al., 2012; Marr et al., 2012; Wendel et al., 2009) . We found that mammalian SEIPIN specifically interacted with the corresponding mammalian GPAT orthologs, GPAT3 and GPAT4. SEIPIN deficiency in yeast, mammalian cells, and mouse tissues resulted in increased GPAT activity and changes in GPAT kinetics. These data strongly suggest that SEIPIN is an evolutionarily conserved regulator of GPAT and that targeting GPAT may have therapeutic potential in treating BSCL2.
RESULTS

Fld1 and Gat1 Physically Interact
To identify potential Fld1/SEIPIN-interacting proteins, we used the native promoter of FLD1 on a low-copy plasmid in wild-type or fld1Δ yeast cells to express GFP alone or a functional Fld1-GFP fusion protein (Fei et al., 2008) . Cell membranes were isolated and solubilized using three different buffer conditions, followed by affinity purification and tandem mass spectrometry analyses (see Experimental Procedures).
In all three buffer/lysis conditions used, 19 proteins co-precipitated with Fld1-GFP, but not with matrix or GFP alone ( Figure S1A ; Table S1 ). Because our previous studies strongly suggested that Fld1/SEIPIN regulates cellular PA content (Fei et al., 2011c; Tian et al., 2011; Jiang et al., 2014) , we focused on the yeast GPAT, Gat1, which catalyzes the rate-limiting step in the de novo synthesis PA and all glycerolipids. Tagged and overexpressed Fld1 and Gat1 were co-immunoprecipitated from yeast ( Figure 1A ), and this interaction was retained when both proteins were expressed at close to endogenous levels by adding tags at the C termini of their respective genomic loci ( Figure 1B ). As recently reported , we also identified Ldb16 as an Fld1-interacting protein in our screen ( Figure S1A ; Table S1 ), and endogenous Ldb16 co-immunoprecipitated with both Fld1-FLAG ( Figure  1B ) and Gat1 ( Figure 1C ). Furthermore, Fld1 and Ldb16 also co-immunoprecipitated with Gat2, a second yeast GPAT that shares ~38% sequence identity and ~58% sequence similarity with Gat1 ( Figures 1C and S1B ). However, a yeast AGPAT homolog, Slc4, did not co-immunoprecipitate with Fld1 as well as Gat1/2 ( Figure 1C ). Fld1-Gat1/2 interaction was not affected in ldb16 null cells ( Figure 1C ), but we were not able to test whether the Ldb16 and Gat1/2 interaction requires Fld1, because Ldb16 is extremely unstable in the absence of Fld1 ; data not shown).
Mammalian SEIPIN and GPAT3/4 Physically Interact
Mammals express four GPAT isoforms; GPAT1 and GPAT2 are present on the outer mitochondrial membrane, and GPAT3 and GPAT4 are present on the ER . GPAT1 is resistant to N-ethylmaleimide (NEM), whereas the other GPATs are sensitive to NEM. SEIPIN co-immunoprecipitated with both GPAT3 and GPAT4 in 3T3L1 preadipocytes (Figure 2A ). The interaction was significantly weakened (by ~50%) between GPAT3/4 and the SEIPIN missense mutant (T78A) that causes a human lipodystrophy (Sim et al., 2013) (Figures 2B and 2C, lane 3; Figures S1D and S1E) . The Cterminal cytoplasmic region of SEIPIN was not essential for the interaction with GPAT3 or GPAT4, because SEIPIN C-terminal truncation mutants could still co-precipitate a significant amount of GPAT3/4 ( Figure S1C ). Importantly, overexpressed SEIPIN immunoprecipitated endogenous GPAT3/4 (the commercial antibody recognizes both GPAT3 and GPAT4) ( Figure 2D ). As an alternative approach, in mature adipocytes, we expressed SEIPIN that was fused to the promiscuous biotin ligase BirA* (Roux et al., 2012) . After affinity purification with streptavidin-conjugated beads, GPAT3/4 was detected only in cells expressing SEIPIN-BirA*, but not SEIPIN or BirA* alone ( Figure 2E ). These data indicate that GPAT3/4 in adipocytes lies in close proximity to SEIPIN. Finally, we employed a proximity ligation assay to further examine the SEIPIN-GPAT3/4 interaction in vivo (Söderberg et al., 2006) . GPAT3 and GPAT4 are closer to SEIPIN than AGPAT2 ( Figure  S2A ) and, consistent with Figure S1C , full-length SEIPIN, but not its C terminus, interacted strongly with GPAT3/4 ( Figures S2B and S2C) . To examine the effects of SEIPIN on GPAT3/4 localization, 3T3-L1 preadipocytes were co-transfected with mCherry-SEIPIN or small hairpin RNA (shRNA) targeting SEIPIN and GFP-tagged mouse GPAT3 or GPAT4 and treated with fatty acids. GPAT3 primarily localizes to LDs, and SEIPIN overexpression or knockdown had little effect on GPAT3 localization ( Figures S3A, S3B , and S3D). GPAT4 localizes to both ER and LDs, and SEIPIN knockdown increased the proportion of GPAT4 on LDs ( Figures S3C, S3E , and S3F).
GPAT Activity Is Increased in SEIPIN-Deficient Cells and Tissues
To test whether SEIPIN interacts with GPAT to regulate its activity, we measured GPAT activity in control and SEIPIN-deficient yeast cells, mammalian cells, and mouse testes. In the absence of SEIPIN, the protein expression of the microsomal GPAT isoforms was virtually unchanged (Figures S4A-S4C ). However, GPAT-specific activity in fld1 null yeast cells was ~60% higher than in controls ( Figure 3A) . In Seipin −/− mouse embryonic fibroblasts (MEFs), the total and microsomal GPAT activities were twice as high as in control MEFs (Figures 3B and S4C) . Similarly, when Seipin was knocked down by ~70% in 3T3L1 preadipocytes, GPAT activity was twice as high as in control preadipocytes ( Figures  3C, S4D , and S4E), and in mouse testes, where Seipin is normally highly expressed, total, NEM-sensitive (GPAT2, 3&4) and NEM-resistant (GPAT1) GPAT activities were 67%, 75%, and 29% higher, respectively, in Bscl2 −/− testes than in controls ( Figures 3D and S4F ).
Taken together, these data demonstrate that SEIPIN downregulates GPAT activity and that this regulatory role is conserved from yeast to mammals.
SEIPIN-Deficient Cells and Tissues Had Altered GPAT Kinetics
Next, we investigated GPAT enzyme kinetics by characterizing the affinity of GPAT for its substrates, glycerol-3-phosphate (glycerol-3-P) and long-chain acyl-CoA. Because acylCoAs are amphipathic and may act as detergents to disrupt membranes and inhibit enzyme activity (Polokoff and Bell, 1978) , the apparent K M values for acyl-CoAs often cannot be accurately calculated. In the absence of SEIPIN, the affinity of GPAT for glycerol-3-P or palmitoyl-coenzyme A (palmitoyl-CoA) was altered in MEFs, 3T3L1 cells ( Figures 3E-3H and S4G-S4J), yeast, and Bscl2 −/− mouse testis ( Figures S4K-S4N ). In each case, GPATspecific activity and V max increased (Table S2) .
Increased GPAT Activity Underpins the Change in LD Morphology in SEIPIN-Deficient Cells
The above data indicate that SEIPIN interacts with GPAT to inhibit its activity. Although the immediate product of GPAT catalysis is lysophosphatidic acid, GPAT is the rate-limiting step, and the next enzyme in this synthetic pathway, lysophosphatidic acyltransferase, rapidly converts lysophosphatidic acid (LPA) to PA. Thus, increasing GPAT activity increases the level of PA in mammalian cells (Zhang et al., 2012a . In yeast, elevated PA in the ER is associated with the formation of "supersized" LDs in fld1 null cells (Fei et al., 2011c) , which had higher GPAT activity . Is the increase in GPAT activity sufficient to raise the amount of PA on the ER and drive the formation of supersized LDs? Indeed, overexpressing wild-type, but not "catalytically dead," GAT1 and GAT2 in yeast cells caused supersized LDs to form (Figures 4A and S5A), phenocopying fld1 null cells. The level of PA in the ER was higher in these cells, similar to fld1 null cells, as indicated by increased INO1 expression ( Figure S5B ) (Loewen et al., 2004) . As detected by mass spectrometry, overexpression of GAT2 increased microsomal PA ( Figure 4B ). Importantly, when either GAT1 or GAT2 was co-expressed with FLD1, the amount of PA in the ER was reduced and few supersized LDs were detected (Figures 4A, 4B, and S5B). These results suggest that loss of Fld1 increases GPAT activity and the level of PA in the ER, causing the formation of supersized LDs.
Supersized LDs are also present in SEIPIN-deficient mature adipocytes and testes, tissues in which SEIPIN is normally highly expressed Liu et al., 2014 alone can dramatically increase LD size ( Figure S5F ). To further investigate the functional relationship between SEIPIN and GPAT at system level, we examined the morphology of the larval salivary gland of Drosophila. Numerous globular structures are present in dSeipin mutants ( Figure 5A ) (Tian et al., 2011) , and these structures can be encircled by a lipid droplet surface marker PLIN1-mCherry ( Figure 5B ), indicating that they are lipid droplets. GPAT (Drosophila gene CG5508) overexpression results in large lipid droplets similar to dSeipin mutants ( Figure 5C ), while overexpressing AGPAT (CG17608), Lipin (CG8709), or DGAT (CG31991) using the same promoter leads to many tiny lipid droplets. ACAT (CG8112) overexpression forms small lipid droplets and aberrant patch-like structures. Finally, knocking down SEIPIN in Drosophila S2 cells increased LD size, which was suppressed by knocking down GPAT simultaneously ( Figure 5D ). Together, these results strongly suggest that increased GPAT activity underpins the formation of supersized LDs in SEIPIN-deficient cells and tissues.
During Early Differentiation, SEIPIN Alters GPAT Kinetics
In addition to its role in modulating LD expansion, SEIPIN is required for normal adipogenesis. Loss of Seipin disrupts adipogenesis within the first few hours of differentiation (Chen et al., 2012; Payne et al., 2008) . We asked whether this feature was also related to SEIPIN's ability to regulate GPAT activity and PA metabolism. We first examined whether the level of PA is disturbed in Seipin knockdown 3T3-L1 preadipocytes by mass spectrometry. As shown in Figures 6A and 6B, total microsomal PA and the majority of PA species were significantly increased upon SEIPIN depletion. We then examined GPAT kinetics during the differentiation of 3T3L1 preadipocytes. In wild-type (WT) cells, the apparent K M values for glycerol-3-P after 0, 4, 8 and 12 hr of differentiation were 176, 267, 176, and 153 μM, respectively ( Figure S6A ), consistent with a transient drop in affinity for glycerol-3-P at 4 hr. In contrast, the apparent K M values for glycerol-3-P in Seipin knockdown cells at the same time points were 113, 147, 142, and 138 μM, respectively, values considerably lower than in the control cells ( Figures S6B and S6C ). These findings suggest the possibility that SEIPIN regulates GPAT kinetics early during differentiation to regulate PA homeostasis.
Increased GPAT3 Activity Impairs Adipogenesis in SEIPIN-Deficient Cells
If SEIPIN deficiency increases GPAT3 activity sufficiently to block adipogenesis, then reducing GPAT3 in SEIPIN-deficient cells should be able to restore adipogenesis. As predicted, in Seipin-deficient 3T3L1 preadipocytes, knocking down Gpat3, but not Gpat4, significantly enhanced adipocyte differentiation ( Figures 6C, 6D , S6D, and S7A-S7E). Finally, to determine whether the increased GPAT activity is sufficient to block adipocyte differentiation, we overexpressed Gpat3 or Gpat4 in 3T3L1 preadipocytes. Overexpression of Gpat3 blocked adipogenesis ( Figures S7F-S7H ), whereas overexpressing Gpat4 had only a moderate inhibitory effect on adipogenesis (data not shown). Importantly, the simultaneous overexpression of Seipin and Gpat3 restored normal differentiation ( Figure S7F-S7H ).
Taken together, these findings strongly support the interpretation that increased GPAT activity underlies the block in adipogenesis in Seipin-deficient cells.
GPAT Inhibitor Partially Rescues the Differentiation of Seipin −/− Preadipocytes
Our results above strongly suggest that pharmacological inhibition of GPAT activity may also restore the differentiation of SEIPIN-deficient cells. Thus, we isolated primary preadipocytes from control and Seipin-deficient mice and differentiated them in the presence or absence of a GPAT inhibitor (formula: C21H26CINO4S) (Outlaw et al., 2014; Wydysh et al., 2009 ). The inhibition was competitive for NEM-sensitive (microsomal) and NEMresistant (mitochondrial) GPAT activities ( Figure 7A ). Inhibition of GPAT at 40 μM increased the number of cells positively stained with Oil red O, as well as the expression of adipogenesis marker genes in Seipin −/− cells ( Figures 7B and 7C ).
DISCUSSION
SEIPIN's role in mammalian lipid storage is unique, because it regulates both adipocyte differentiation and the expansion of cellular LDs (Fei et al., 2011a) . However, as an integral membrane protein of the ER without known functional domains, SEIPIN's mechanism of action has been difficult to understand. Here, we demonstrate that SEIPIN and its yeast ortholog, Fld1, can interact specifically with the ER-located GPAT isoforms and that this evolutionarily conserved interaction diminishes the specific activity of both yeast and mammalian GPAT isoforms and alters their substrate affinities. Our data provide strong evidence that when SEIPIN is absent, enhanced microsomal GPAT activity results in defective adipogenesis and altered LD morphology.
The acylation of glycerol-3-P, catalyzed by GPAT, is the initial and rate-limiting step in the synthesis of triacylglycerol and the glycerophospholipids. The mitochondrial isoform GPAT1 contributes between 20% and 50% of the total GPAT activity in liver but only ~10% of total GPAT activity in other tissue types . A second mitochondrial GPAT isoform, GPAT2, is expressed primarily in testes. The microsomal GPAT isoforms, GPAT3 and GPAT4, have an 80% amino acid identity and, like the two Gat isoforms in yeast, are integral membrane proteins of the ER (Marr et al., 2012) but may move to the surface of LDs during LD expansion (Wilfling et al., 2013) . Similarly, yeast Gat1 may be present on LDs during the stationary phase of yeast growth (Marr et al., 2012) . Insulin increases the activities of mammalian GPAT3 and GPAT4 by phosphorylation at Ser and Thr residues, although the functional outcome of these modifications is unclear (Shan et al., 2010) . Overall, the regulation of the ER GPATs remains largely unexplored, and no GPAT-interacting proteins have previously been identified.
Through a non-biased screen in yeast, we identified the yeast GPAT, Gat1, as a potential interacting partner of the yeast SEIPIN ortholog, Fld1. Multiple lines of evidence support a specific physical association between orthologs of SEIPIN and ER GPATs. Yeast and mammalian SEIPIN were co-immunoprecipitated with their respective yeast and mammalian GPAT orthologs, and both biotinylation and proximity ligation assays confirmed the close proximity of SEIPIN and GPAT3/4. Interestingly, compared to wild-type SEIPIN, the disease-causing missense mutant T78A had a weakened association with GPAT3/4. These data strongly support a specific physical association between SEIPIN and GPAT3/4. However, because both SEIPIN and the ER GPATs are integral membrane proteins that have resisted purification, we are unable to determine their stoichiometry in vitro or whether their interaction is direct. Because SEIPIN forms oligomers (Sim et al., 2013; Binns et al., 2010; Fei et al., 2011b) , it is possible that a single GPAT3/4 molecule may interact with a SEIPIN oligomer. Moreover, whether SEIPIN missense mutants such as T78A cause lipodystrophies through reduced interaction with GPAT remains inconclusive, and future studies will focus on this aspect.
The specific link between orthologs of SEIPIN and the ER GPAT isoforms was strongly and consistently supported by functional assays. SEIPIN deficiency is associated with two striking phenotypes: (1) a near complete block in adipogenesis and (2) the enlargement of LDs in yeast and in those mammalian cells and tissues in which SEIPIN is normally highly expressed, such as testes and mature adipocytes Jiang et al., 2014 ). SEIPIN's association with the ER GPAT isoforms can explain its roles in adipogenesis and LD expansion. As illustrated in Figure S8 , our data support the hypothesis that when SEIPIN interacts with the ER GPATs, their enzymatic activity is reduced and the production of PA is diminished. Thus, the normal interaction of SEIPIN and the ER GPAT isoforms results in two major consequences: (1) because PA inhibits PPARγ, low GPAT activity during the first few hours of adipocyte differentiation permits PPARγ to be fully active, so that normal adipogenesis can proceed; and (2) in mature adipocytes, yeast, and other cells, SEIPINregulated ER GPAT activity controls the size of LDs, possibly by limiting the amount of fusogenic PA ( Figure S7 ). Conversely, in the absence of SEIPIN, ER GPAT-specific activity is enhanced and PA production increases. The high PA concentration may inhibit PPARγ activity or other signaling pathways in preadipocytes, thereby blocking adipogenesis (Stapleton et al., 2011; Zhang et al., 2012b; Nadra et al., 2012) . In other cells, the absence of SEIPIN also results in high GPAT activity and increased local production of PA at the ER, resulting in aberrant LD budding and growth and the formation of supersized LDs (Fei et al., 2011c) . Several critical experiments support this interpretation, including the altered GPAT kinetics when SEIPIN is absent, the near-normal adipocyte differentiation that occurs when both SEIPIN and GPAT3 are absent, the formation of supersized LDs when the ER GPATs are overexpressed, and the reduction in LD size when SEIPIN and GPAT are co-expressed.
SEIPIN has been reported to interact with two other glycerolipid synthetic enzymes, AGPAT2 and LIPIN1 (Talukder et al., 2015; Sim et al., 2012) . However, there is a fundamental difference between those studies and ours. SEIPIN was proposed to facilitate AGPAT2 and LIPIN1 function, whereas our data suggest that SEIPIN inhibits GPATs. Moreover, although the interaction of SEIPIN with AGPAT2 and LIPIN1 is relevant for the metabolism of PA, GPAT is recognized as the rate-limiting enzyme in the pathway. Importantly, the notion that SEIPIN anchors and facilitates LIPIN function overlooks existing physiological evidence (Talukder et al., 2015) . For example, depleting lipin-1 in mouse adipocytes reduces the size of LDs, whereas depleting Seipin in mouse adipocytes increases LD size (Nadra et al., 2012; Liu et al., 2014) . Furthermore, our coimmunoprecipitation study in yeast could not detect a SEIPIN-LIPIN1 interaction (data not shown), and the yeast AGPAT2 homolog, Slc4, did not co-precipitate well with Fld1. Importantly, when overexpressed in the salivary gland of Drosophila under the same promoter, GPAT is the only enzyme that gave rise to supersized LDs. In Drosophila, SEIPIN has been reported to interact with sarco/endoplasmic reticulum calcium ATPase (SERCA), an ER-specific calcium pump (Bi et al., 2014) . However, alterations in ER fatty acid and lipid composition are known to inhibit SERCA activity (Fu et al., 2011) . Because our results support a primary function of SEIPIN in ER phospholipid metabolism, the disrupted calcium homeostasis observed in SEIPIN-deficient cells may be secondary to an altered ER phospholipid composition. Recent data also suggest that SEIPIN is involved in the vectorial export of TAG from the ER or the stabilization of ER-LD contact sites (Cartwright et al., 2015; Grippa et al., 2015) . Our findings described here do not necessarily contradict with those observations; changes in PA concentration/localization of the ER may also impact the vectorial budding of droplets and/or the phospholipid composition of LDs (Wolinski et al., 2015; Han et al., 2015) .
Although both GPAT3 and GPAT4 can interact with SEIPIN, they exhibited clear functional differences. Overexpressing either enzyme altered LD morphology at least in Huh7 cells, but only GPAT3 appeared to play a major role in adipogenesis (Shan et al., 2010) . Surprisingly, although GPAT3 is highly upregulated in differentiating adipocytes, Gpat3 −/− mice had relatively modest phenotypic alterations, and decreased weight gain was detected only when Gpat3 −/− mice were fed a high-fat diet (Cao et al., 2014) . GPAT4 is moderately upregulated during adipogenesis, but it is the major microsomal GPAT activity in brown adipose tissue, where its presence is required to limit the oxidation of exogenous fatty acids (Cooper et al., 2015) . Murine GPAT4 is known to localize to LDs (Wilfling et al., 2013) ; however, our data suggest that both ER GPATs can localize to LDs, particularly GPAT3.
Taken as a whole, our data provide strong evidence that SEIPIN interacts with and regulates ER GPATs in mammalian cells, fly, and S. cerevisiae. This is the first example of an evolutionarily conserved, physiological regulator of the ER GPATs.
EXPERIMENTAL PROCEDURES Materials
Strains, primers, plasmids, and antibodies are listed in Tables S3-S7. [ 3 H] Glycerol-3-P was synthesized enzymatically (Chang and Kennedy, 1967) .
Isolation of Fld1-Interacting Proteins
Wild-type yeast cells transformed with plasmid pLacYCP-GFP and fld1Δ cells transformed with pLacYCP-Fld1-GFP were grown to early stationary phase and then lysed using a bead beater in three different buffers: buffer 1 (25 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.5% Triton X-100, 0.2 mM EDTA, and 0.2 mM DTT), buffer 2 (20 mM K-HEPES [pH 7.4], 110 mM CH 3 CO 2 K, 150 mM NaCl, 0.1% Triton X-100, 0.1% Tween 20, and 2 mM MgCl 2 ), and buffer 3 (20 mM K-HEPES [pH 7.4], 110 mM CH 3 CO 2 K, 150 mM NaCl, 0.1% Triton X-100, 0.1% Tween 20, 46 mM n-octyl-B-D-glucopyranoside, 2 mM MgCl 2 , and 5% glycerol). Cell lysates were initially incubated with Sepharose CL-4B (GE Healthcare) to pull down proteins interacting with beads, and the supernatants were affinity purified using a GFP-Trap (ChromoTek) (Rothbauer et al., 2008) to pull down proteins interacting with GFP and Fld1-GFP, respectively.
Identification of Fld1-Interacting Candidates
Proteins were eluted from Sepharose and GFP-Trap beads with a low-pH buffer (pH 2) containing 100 mM glycine, neutralized, and separated on 4%-15% Tris-HCl gels (BioRad). After staining with Coomassie brilliant blue R-250 (Sigma), protein bands were digested in-gel with trypsin (Shevchenko et al., 1996) , and the sequences of the resultant peptides were determined by liquid chromatography tandem mass spectrometry using LTQOrbi-trap Velos Pro (Thermo Fisher Scientific) coupled to UltiMate 3000 RSLC (Dionex). A list of candidate interactors was created from proteins identified in at least three Fld1-GFP pull-downs and absent in the controls (Table S1 ). Proteins were identified by at least two unique unmodified peptides with a score of −20.
Yeast Growth
Yeast cells were grown as described previously (Sherman, 2002) .
Mammalian Cell Culture
HeLa, MEF, 3T3-L1, HEK293FT, and Phoenix Eco cells were grown in DMEM, 10% fetal bovine serum (FBS) (Invitrogen), and 100 U/mL penicillin and streptomycin. Cells were transiently transfected with plasmids using Lipofectamine LTX/Plus (Invitrogen). To induce triacylglycerol synthesis and LD formation, cells were incubated for 16 hr with 400 or 800 μM BSA-coupled oleate.
Retro-and Lentivirus Production and Stable Cell Line Generation
pLKO.1-based shRNA lentiviral or pBABE-based retroviral expression constructs (Table  S6) were used to generate lentivirus in HEK293T cells or retro-virus in Phoenix Eco cells, respectively. 3T3-L1 cells were incubated for 24 hr with lenti-or retrovirus together with 8 μg/mL polybrene. Stable cells were selected with 4 μg/mL puromycin and/or 800 μg/mL neomycin for 10 days before use or storage in liquid N 2 .
Adipocyte culture and differentiation and qRT-PCR were carried out as described previously (Chen et al., 2012; Payne et al., 2008) .
Pre-adipocyte Isolation and Differentiation
Animal protocols were approved by the University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee. Mouse preadipocytes were isolated from gonadal adipose tissue. After excising blood vessels, adipose tissue was minced into small pieces, decanted into isolation medium (DMEM supplemented with 25 mM HEPES, 2% BSA, and 2 mg/mL collage-nase), and digested for 30 min at 37°C with constant shaking. Suspended cells were then filtered through a 100-μm nylon filter, centrifuged for 5 min at 400 × g, and resuspended in DMEM supplemented with 10% newborn calf serum and 100 U/mL penicillin and streptomycin. Differentiation was carried out as described above, and the GPAT inhibitor was present during the first 48 hr of differentiation.
GPAT Activity and Kinetics
The right testis or MEFs and 3T3L1 cells from 10-cm dishes were homogenized in cold medium I (250 mM sucrose, 10 mM Tris [pH 7.4], 1 mM EDTA, 1 mM DTT) using 10 upand-down strokes with a Teflon-glass motor-driven homogenizer. Total membranes were isolated by centrifuging the homogenate at 100,000 × g for 1 hr. GPAT specific activity (initial rates) was assayed for 10 min at room temperature (RT) in a 200 μL reaction mixture containing 75 mM Tris-HCl (pH 7.5), 4 mM MgCl 2 , 1 mg/mL BSA (essentially fatty-acidfree), 1 mM DTT, 8 mM NaF, 800 μM [ 3 H]glycerol-3-P, and 82.5 μM palmitoyl-CoA. Membrane protein was incubated on ice for 15 min in the presence or absence of 2 mM NEM, which inactivates GPAT isoforms 2, 3, and 4 (Lewin et al., 2004) . The reaction was initiated by adding 20 μg (testis), 15 μg (MEFs), or 5 μg (3T3L1) of membrane protein.
Reaction products were extracted into 2 mL CHCl 3 . NEM-resistant activity (GPAT1) was calculated by subtracting NEM-sensitive activity from total activity. To determine the reaction products, 1 mL of the CHCl 3 extract was dried under N 2 , resuspended in 30 μL CHCl 3 :CH 3 OH (2:1; v/v), and separated by thin-layer chromatography (CHCl 3 :pyridine: 88% formic acid, 50:30:7; v/v). More than 90% of the reaction product was PA, and the remainder was lysophosphatidic acid. 
Co-immunoprecipitation and Western Blotting
Antibodies used are listed in Table S8 . Yeast cell lysates were prepared as described previously (Fei et al., 2008) . 2 mg protein was used for each co-immunoprecipitation condition. Antibody was immobilized on magnetic Dynabeads (Dynabeads CoImmunoprecipitation Kit manual). After 30 min of incubation with the cell lysates containing overexpressed protein at RT, or after overnight incubation with the cell lysates containing low levels of recombinant protein at 4°C, beads were washed and eluted at 37°C for 20 min. Proteins were transferred onto polyvinylidene fluoride (PVDF) membranes, followed by immunodetection (Fei et al., 2008) .
Transiently or stably transfected mammalian cells (MEFs, mouse 3T3-L1preadipocytes, and HeLa cells) were washed three times with ice-cold PBS and lysed in immunoprecipitation (IP) lysis/wash buffer (as above) containing 1% (w/v) n-dodecyl-β-D-maltopyranoside (DDM; Sigma) by forcing the cells 30 times through a 0.8-mm needle. Immunoprecipitation and western blotting were carried out as described above.
BirA* Pull-Down Assays
The cDNA for BirA* was subcloned from pGEM-SD2-BirA* (a kind gift of John Strouboulis, Erasmus University Medical Center, Rotterdam, the Netherlands). 3T3-L1 preadipocytes were transduced with FLAG-tagged SEIPIN, FLAG-tagged biotin ligase BirA*, or FLAG-tagged BirA*-SEIPIN delivered using retrovirus, and cells were then induced to differentiate to mature adipocytes. On day 8 of differentiation, cells were treated with 50 μM biotin for 24 hr and then lysed. Cell lysates were precleared with empty protein G agarose beads for 4 hr and then incubated with streptavidin-conjugated agarose for 2 hr at room temperature. The beads were collected and washed with buffers as described previously (Roux et al., 2012) , incubated with sample buffer containing 1.5 mM biotin, and heated for 1 hr at 65°C before western blot analysis.
Proximity Ligation Assay
HeLa cells transfected with indicated plasmids were fixed with 4% paraformaldehyde (Electron Microscopy Sciences) for 15 min and permeabilized with 0.2% Triton X-100 (Sigma-Aldrich) for 10 min at room temperature. Cells were then blocked with 3% BSA in PBS for 1 hr and incubated with appropriate combinations of mouse anti-FLAG (1:100; Clontech Laboratories) and rabbit anti-HA (1:3,000; CST) antibodies diluted in blocking solution for 1 hr at room temperature. This was followed by proximity ligation assay using the Du-olink detection reagent kit (Olink Bioscience) according to the manufacturer's protocol. Fluorescence images were acquired using an Olympus Fluoview FV1200 confocal microscope with a 60×/1.35 UPlanSApo objective. Images were prepared and analyzed with Fiji software (http://fiji.sc). For each experiment, signals from at least 50 cells were quantified. All data were analyzed using GraphPad PRISM software.
Fluorescence Microscopy
Yeast cells were stained with 20 μg/mL Nile red (Sigma-Aldrich). For mammalian lipid droplets, BODIPY 493/503 (Invitrogen) was used. Imaging was performed using a Leica SP5 confocal microscope and a Leica HCX 63× 1.4 numerical aperture objective.
Lipidomic Analysis of Microsomal PA
Phospholipids were extracted from microsomes isolated from yeast or mammalian cells, subjected to high performance liquid chromatography (HPLC) tandem mass spectrometry (MS/MS) and analyzed using Lipid Search software as described (Qi et al., 2016; Fei et al., 2011c) . Drosophila experiments are as described previously (Tian et al., 2011) . ppl-Gal4 was used to drive the overexpression of genes indicated.
Statistics
Experiments were performed in triplicate. The results are presented as mean ± SD. Twotailed Student's t test was used for comparison. See also Figure S1 and Table S1 . 
